Medical Device Regulatory Consulting for Indian Exporters

For selling into the United States, the Food and Drug Administration (FDA) is the primary agency overseeing medical devices under 21 CFR. On the India side, manufacturers work with the CDSCO for export clearance and a free-sale certificate. Other markets have their own bodies — the EMA under EU MDR, Health Canada, Japan's PMDA — but for US entry, FDA establishment registration and device listing are what matter most.

Quality Assurance (QA) covers the internal processes and controls that keep a device consistently meeting standards like ISO 13485 and GMP. Regulatory Affairs (RA) manages the external relationship with agencies — FDA submissions, device listing, labeling, and ongoing 21 CFR compliance. For an India-based exporter entering the US, both matter: strong QA supports your ISO 13485 file, while RA drives your US FDA registration and 510(k) where required.

21 CFR (Code of Federal Regulations, Title 21) is the US federal law governing devices regulated by the FDA. For medical devices, Part 820 covers Quality System Regulations, Part 801 covers labeling, and Part 807 covers pre-market notification (510(k)). Any India-made device legally marketed in the US must comply with the applicable 21 CFR parts, regardless of its CDSCO status back home.

Medical device regulatory refers to the framework of laws, standards, and agency guidelines governing how devices are designed, made, labeled, distributed, and monitored. For an India-based brand, it spans your CDSCO export documentation, US FDA establishment registration and device listing, ISO 13485, GMP, UDI labeling, and 510(k) where applicable. Regulatory guidance helps you navigate these efficiently, reducing the risk of border delays, Import Alerts, or enforcement actions.

Regulatory support fees vary with project scope, device classification, and pathway complexity. Hourly industry rates typically range from $150 to $400, while full submission or quality-system projects can run from $5,000 to $50,000 or more. At Blue Bonnet Supplies, we work with India-based exporters to provide transparent, customized pricing scoped to your specific device and US entry plan.

21 CFR Part 820 is the FDA's Quality System Regulation for device makers in the US, while ISO 13485 is an internationally recognized quality management standard. Both address quality systems but differ in scope — 21 CFR 820 is a US legal requirement enforced by the FDA, while ISO 13485 is globally recognized and often what India-based manufacturers already hold. A strong ISO 13485 file gives you a running start toward US FDA compliance.

FDA timelines vary by submission type. A standard 510(k) pre-market notification typically takes 90 to 150 days of FDA review, with preparation adding several months; De Novo requests can take 150 days or more, and PMA applications for Class III devices a year or more. For India-based exporters, well-prepared submissions with complete documentation reduce back-and-forth and get your device to US buyers sooner.

Yes. Regulatory obligations don't end at clearance. You must maintain post-market surveillance, submit MDR reports for adverse events, manage labeling changes, track design modifications that may need new submissions, and keep your quality records current. For an India-based exporter running US distribution from afar, ongoing compliance monitoring is what keeps devices clearing customs and avoids warning letters or recalls.